Agents that interfere with TLR4/NF-κB/NLRP3 inflammasome signaling in the hippocampal tissues were proven to significantly mitigate the neuroimmune dysregulation frequently encountered in autism [60]. The gene discussed is NLRP3; the disease is autism.